WHO ICTRP trial
Pretreatment with dezocine reduces myoclonus after etomidate
ChiCTR-IPR-17010340 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR-IPR-17010340 |
|---|---|
| Public title | Pretreatment with dezocine reduces myoclonus after etomidate |
| Scientific title | Comparison of effects of dezocine and fentanyl on hemodynamic response and myoclonus in the patients with etomidate induction |
| Primary sponsor | The First Affiliated Hospital of Henan University of Traditional Chinese Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | Post-market |
| Countries | China |
| Conditions | myoclonus |
| Interventions | dezocine:dezocine;fentanyl group:fentanyl;saline group:saline |
| Registration date | Jan 6, 2017 |
| Target size | dezocine:40;fentanyl group:40;saline group:40 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: